$0.384
-0.030 (-7.79%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CNTX Prediction & Forecast by Similar Chart Analysis
Alphio's CNTX stock price prediction model matches the current Context Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.38 (-1.41%). The 1-week path is $0.39 (+0.57%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Context Therapeutics Inc Stock?
Context Therapeutics Inc (CNTX) is not a good buy right now. The stock is currently trading at $0.38, down 75.25% year-to-date, indicating significant downward momentum. The RSI is at a very low 18.91, suggesting it is oversold, but the overall financial performance shows a widening net loss of $14.56 million in Q2 2026, which is a 65% increase year-over-year. The main risk is the company's ongoing financial losses, with a net income of -$14.56 million and a current ratio of 5.81, indicating potential liquidity issues. Despite its inclusion in the Russell indices, the stock's recent performance and financial health do not support a buy recommendation.
CNTX stock price ended at $0.38 on Friday, after losing -7.79%
Context Therapeutics Inc (CNTX) last closed at $0.3837, losing -7.79%. These facts feed the 1-day and 1-week CNTX price prediction above.
Forecast Drivers
Context Therapeutics Inc (CNTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CNTX, ranked by similarity.
Seasonality analysis for CNTX
Historically the probability of a positive August return for CNTX is 34.92%. October offers the highest probability of a positive month at 80.43%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CNTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.85 | $0.92 | $1.11 | +140.91% |
| Sep 2026 | $0.78 | $0.79 | $0.80 | +107.02% |
| Oct 2026 | $0.88 | $0.98 | $1.16 | +155.36% |
| Nov 2026 | $0.89 | $1.01 | $1.14 | +163.98% |
| Dec 2026 | $0.79 | $0.89 | $0.98 | +131.63% |
In 2026, Context Therapeutics Inc (CNTX) is projected to range from $0.78 to $1.16.
Context Therapeutics Inc 2026 monthly forecast
In Aug 2026, Context Therapeutics Inc is projected to average $0.92, with a low of $0.85 and high of $1.11.
In Sep 2026, Context Therapeutics Inc is projected to average $0.79, with a low of $0.78 and high of $0.80.
In Oct 2026, Context Therapeutics Inc is projected to average $0.98, with a low of $0.88 and high of $1.16.
In Nov 2026, Context Therapeutics Inc is projected to average $1.01, with a low of $0.89 and high of $1.14.
In Dec 2026, Context Therapeutics Inc is projected to average $0.89, with a low of $0.79 and high of $0.98.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.